A wellness product called RecoveryFirefly was on Shark Tank last night, asking $500k for 2.5% of the company ($20 million valuation). They started in 2022, had $4 million revenue last year and will do $5.5 million this year. The product is a simple band that supposedly improves blood flow in the legs and they claim it helps the body recover after strenuous activity. It cost $17.30 "landed" to make and sells for $48 according to what they said on the show, but their website indicates it sells for much more. They wound up accepting an offer of $500k for 5% of the company.
In comparison, BIEL is way undervalued as Actipatch is a much better product, FDA cleared, more cost effective, and promotes healing in addition to recovery. All that's needed is that marketing/advertising break-through. A pr or news release that gets the pps moving up may be the most cost effective way to spread the word about BIEL and it's products (via the financial press) and capitalize on the "buzz" and "awareness" about recovery products generated by yesterday's Shark Tank episode.
(1)
(0)
BioElectronics Corporation (BIEL) Stock Research Links